Golden Sun Health Technology Group Limited - Class A Ordinary Shares (GSUN)
2.8700
-0.0600 (-2.05%)
NASDAQ · Last Trade: Apr 2nd, 9:03 PM EDT
Detailed Quote
Previous Close | 2.930 |
---|---|
Open | 2.830 |
Bid | 2.870 |
Ask | 3.070 |
Day's Range | 2.830 - 3.050 |
52 Week Range | 2.210 - 9.930 |
Volume | 29,886 |
Market Cap | - |
PE Ratio (TTM) | - |
EPS (TTM) | - |
Dividend & Yield | N/A (N/A) |
1 Month Average Volume | 17,231 |
About Golden Sun Health Technology Group Limited - Class A Ordinary Shares (GSUN)
Golden Sun Health Technology Group Limited is a public company focused on the development and provision of innovative health technology solutions. Their operations encompass a range of health-related services and products designed to enhance wellness and improve healthcare outcomes. The company is dedicated to leveraging advanced technology in the health sector, aiming to offer effective and efficient solutions that address the needs of patients and healthcare providers alike. With a commitment to research and development, Golden Sun Health seeks to stay at the forefront of health innovation and contribute to the evolution of modern healthcare practices. Read More
News & Press Releases

Via Benzinga · December 4, 2024

Via Benzinga · October 2, 2024

Via Benzinga · September 26, 2024

Via Benzinga · August 20, 2024

Via Benzinga · July 19, 2024

Via Benzinga · June 4, 2024

Via Benzinga · May 31, 2024

Via Benzinga · May 29, 2024

Via Benzinga · May 16, 2024

Via Benzinga · May 14, 2024
Investor Spotlight: Companies Poised for Growth Amid Recent Developments: VTAK, ESPR, FGEN, GSUN, INBS
Given recent developments, several companies are anticipated to attract investor attention, making it an opportune moment to examine these events more closely. This feature will offer insights into five such companies.
Via AB Newswire · May 8, 2024

Via Benzinga · May 7, 2024

Via Benzinga · May 7, 2024

Via Benzinga · May 7, 2024

Via Benzinga · May 3, 2024

Via Benzinga · May 1, 2024

Via Benzinga · April 29, 2024

Via Benzinga · April 19, 2024

Via Benzinga · April 16, 2024